Suchergebnisse - "Greig, Nigel H"

PubPharm (11)

1

Adiponectin as a Potential Therapeutic Target for Prostate Cancer

enthalten in: Current pharmaceutical design | 2017

von Karnati, H. | Panigrahi, M. | Li, Y. | +2

2

Editorial: Frontier Views in Designing Therapeutic Candidates for Management of Diverse Diseases

enthalten in: Current pharmaceutical design | 2017

von Kamal, M. | Greig, N.

3

Adiponectin as a Potential Therapeutic Target for Prostate Cancer

enthalten in: Current pharmaceutical design | 2017

von Karnati, H. | Panigrahi, M. | Li, Y. | +2

4

Editorial : Frontier Views in Designing Therapeutic Candidates for Management of Diverse Diseases

enthalten in: Current pharmaceutical design | 2017

von Kamal, M. | Greig, N.

5

Neuroprotective Mechanisms Mediated by CDK5 Inhibition

enthalten in: Current pharmaceutical design | 2016

von Mushtaq, G. | Greig, N. | Anwar, F. | +4

6

Editorial : Managing Strategies for Diverse Diseases: Challenges from Bench to Bedside Translation in Successful Drug Discovery and Development

enthalten in: Current pharmaceutical design | 2016

von Kamal, M. | Greig, N.

7

Engineered Nanoparticles Against MDR in Cancer : The State of the Art and its Prospective

enthalten in: Current pharmaceutical design | 2016

von Ahmad, J. | Akhter, S. | Greig, N. | +3

8

Editorial : Managing Strategies for Diverse Diseases: Challenges from Bench to Bedside Translation in Successful Drug Discovery and Development (Part B)

enthalten in: Current pharmaceutical design | 2016

von Kamal, M. | Greig, N.

9

Editorial (Thematic Issue : Managing Strategies for Diverse Diseases: Challenges from Bench to Bedside Translation in Successful Drug Discovery and Development (Part C))

enthalten in: Current pharmaceutical design | 2016

von Kamal, M. | Greig, N.

10

Neuroprotective Mechanisms Mediated by CDK5 Inhibition

enthalten in: Current pharmaceutical design | 2016

von Greig, N. | Al-Abbasi, F. | Mushtaq, G. | +4